Hui Qian

642 total citations
17 papers, 432 citations indexed

About

Hui Qian is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Hui Qian has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Hui Qian's work include MicroRNA in disease regulation (9 papers), Extracellular vesicles in disease (8 papers) and Circular RNAs in diseases (7 papers). Hui Qian is often cited by papers focused on MicroRNA in disease regulation (9 papers), Extracellular vesicles in disease (8 papers) and Circular RNAs in diseases (7 papers). Hui Qian collaborates with scholars based in China, Australia and Ghana. Hui Qian's co-authors include Wenrong Xu, Jiajia Jiang, Xu Zhang, Xueyan Zang, Maoye Wang, Hui Shi, Yu Zhang, Han Shen, Zhimin Tao and Ying‐Hong Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Journal of Controlled Release.

In The Last Decade

Hui Qian

17 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui Qian China	12	330	231	47	39	34	17	432
Jingchao Zhou China	7	264 0.8×	171 0.7×	26 0.6×	34 0.9×	27 0.8×	7	354
Xinghong Yao China	9	336 1.0×	209 0.9×	48 1.0×	55 1.4×	43 1.3×	22	468
Yingru Xu China	9	218 0.7×	119 0.5×	70 1.5×	32 0.8×	33 1.0×	20	322
Defa Huang China	12	269 0.8×	157 0.7×	49 1.0×	47 1.2×	32 0.9×	30	412
Xiaoyue Cao China	8	298 0.9×	177 0.8×	47 1.0×	43 1.1×	28 0.8×	11	438
Nicholas H. Farina United States	10	442 1.3×	320 1.4×	69 1.5×	26 0.7×	43 1.3×	17	552
Zhengming Zhu China	14	273 0.8×	223 1.0×	48 1.0×	25 0.6×	44 1.3×	23	395
Miaoyun Long China	14	239 0.7×	166 0.7×	61 1.3×	37 0.9×	44 1.3×	37	451
Kunkun Xia China	7	396 1.2×	352 1.5×	40 0.9×	43 1.1×	24 0.7×	9	490

Countries citing papers authored by Hui Qian

Since Specialization

Citations

This map shows the geographic impact of Hui Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Qian more than expected).

Fields of papers citing papers by Hui Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Qian. The network helps show where Hui Qian may publish in the future.

Co-authorship network of co-authors of Hui Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Qian. A scholar is included among the top collaborators of Hui Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Qian. Hui Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Shen, Ye, Xueyan Zang, Peipei Wu, et al.. (2025). Neutrophil membrane engineered human umbilical cord MSC-derived sEVs enhance anti-tumor efficacy for gastric cancer via delivering pentraxin 3. Journal of Controlled Release. 383. 113828–113828. 3 indexed citations

Jin, Can, Peipei Wu, Wei Wu, et al.. (2025). Therapeutic role of hucMSC-sEV-enriched miR-13896 in cisplatin-induced acute kidney injury through M2 macrophage polarization. Cell Biology and Toxicology. 41(1). 50–50. 8 indexed citations

Yu, Peng, et al.. (2024). Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)‐induced differentiation therapy for hepatocellular carcinoma. Journal of Digestive Diseases. 25(4). 255–265. 2 indexed citations

Wang, Min, Dakai Yang, Peipei Wu, et al.. (2024). A Dual Role of Mesenchymal Stem Cell Derived Small Extracellular Vesicles on TRPC6 Protein and Mitochondria to Promote Diabetic Wound Healing. ACS Nano. 18(6). 4871–4885. 26 indexed citations

Zang, Xueyan, Rongrong Wang, Ziyi Wang, et al.. (2024). Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217/HNF1B axis. Translational Oncology. 45. 101969–101969. 9 indexed citations

Chen, Yanxia, et al.. (2024). CD8+ T cell-based cancer immunotherapy. Journal of Translational Medicine. 22(1). 394–394. 44 indexed citations

Zhu, Junyan, et al.. (2024). Emerging role of extracellular vesicles in diabetic retinopathy. Theranostics. 14(4). 1631–1646. 17 indexed citations

Li, Qing, Bo Li, Wenrong Xu, et al.. (2023). Requirements for human pluripotent stem cell derived small extracellular vesicles. SHILAP Revista de lepidopterología. 1(2). 9 indexed citations

Li, Qing, Bo Li, Wenrong Xu, et al.. (2023). Requirements for human mesenchymal stem cell‐derived small extracellular vesicles. SHILAP Revista de lepidopterología. 1(1). 26 indexed citations

10.

Li, Rong, Xinyu Tian, Jiajia Jiang, et al.. (2023). CircRNA CDR1as: a novel diagnostic and prognostic biomarker for gastric cancer. Biomarkers. 28(5). 448–457. 22 indexed citations

11.

Wang, Jingyan, Bing Pei, Xinwei Xu, et al.. (2022). hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis. Molecular Pharmaceutics. 19(2). 484–493. 21 indexed citations

12.

Zang, Xueyan, Jiajia Jiang, Jianmei Gu, et al.. (2022). Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1. Molecular Cancer. 21(1). 141–141. 52 indexed citations

13.

Wang, Dongli, et al.. (2022). Exosomal circRNAs: Novel biomarkers and therapeutic targets for gastrointestinal tumors. Biomedicine & Pharmacotherapy. 157. 114053–114053. 18 indexed citations

14.

Jiang, Jiajia, Rong Li, Junyi Wang, et al.. (2021). Circular RNA CDR1as Inhibits the Metastasis of Gastric Cancer through Targeting miR-876-5p/GNG7 Axis. Gastroenterology Research and Practice. 2021. 1–13. 17 indexed citations

15.

Zhang, Lu, Dickson Kofi Wiredu Ocansey, Chinasa Valerie Olovo, et al.. (2021). Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease. Biomedicine & Pharmacotherapy. 140. 111752–111752. 27 indexed citations

16.

Zhang, Yu, Jiajia Jiang, Jiayin Zhang, et al.. (2021). CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Molecular Cancer. 20(1). 101–101. 117 indexed citations

17.

Zhao, Ming, et al.. (2020). Bioinformatics analysis of microRNA profiles and identification of microRNA-mRNA network and biological markers in intracranial aneurysm. Medicine. 99(31). e21186–e21186. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact